P. Cardiello

发表

Highly Active Antiretroviral Therapy (HAART) Retreatment in Patients on CD4-Guided Therapy Achieved Similar Virologic Suppression Compared With Patients on Continuous HAART: The HIV Netherlands Australia Thailand Research Collaboration 001.4 Study

B. Hirschel, J. Ananworanich, K. Ruxrungtham, 2005, Journal of acquired immune deficiency syndromes.

Establishment of a public antiretroviral treatment clinic for adults in urban Botswana: lessons learned.

R. Marlink, P. Cardiello, H. Moffat, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Incidence and risk factors for rash in Thai patients randomized to regimens with nevirapine, efavirenz or both drugs

J. Ananworanich, K. Ruxrungtham, D. Cooper, 2005, AIDS.

UvA-DARE ( Digital Academic Repository ) A prospective , randomized trial of structured treatment interruption for patients with chronic HIV type 1 infection

B. Hirschel, J. Ananworanich, K. Ruxrungtham, 2005 .

Pharmacokinetics of once-daily saquinavir hard-gelatin capsules and saquinavir soft-gelatin capsules boosted with ritonavir in HIV-1-infected subjects.

K. Ruxrungtham, D. Cooper, P. Phanuphak, 2003, Journal of acquired immune deficiency syndromes.

The 48‐week efficacy of once‐daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapy

K. Ruxrungtham, D. Cooper, P. Phanuphak, 2005, HIV medicine.

Initial Response to Highly Active Antiretroviral Therapy in HIV-1C-Infected Adults in a Public Sector Treatment Program in Botswana

I. Thior, A. Mujugira, M. Essex, 2005, Journal of acquired immune deficiency syndromes.

Simplifying Protease Inhibitor Therapy with Once‐Daily Dosing of Saquinavir Soft‐Gelatin Capsules/Ritonavir (1600/100 mg): HIVNAT 001.3 Study

K. Ruxrungtham, D. Cooper, J. Beijnen, 2002, Journal of acquired immune deficiency syndromes.

Pharmacokinetics of Lower Doses of Saquinavir Soft-Gel Caps (800 and 1200 Mg Twice Daily) Boosted with Itraconazole in HIV-1-Positive Patients

K. Ruxrungtham, D. Cooper, P. Phanuphak, 2002, Antiviral therapy.

Strengthening Healthcare Capacity Through a Responsive, Country-Specific, Training Standard: The KITSO AIDS Training Program’s Sup-port of Botswana’s National Antiretroviral Therapy Rollout

M. Mine, R. Marlink, D. Baxter, 2008, The open AIDS journal.

Highly Active Antiretroviral Therapy (HAART) Retreatment in Patients on CD4-Guided Therapy Achieved Similar Virologic Suppression Compared With Patients on Continuous HAART: The HIV Netherlands Australia Thailand Research Collaboration 001.4 Study

B. Hirschel, J. Ananworanich, K. Ruxrungtham, 2005, Journal of Acquired Immune Deficiency Syndromes.

Mutations and Polymorphisms Associated with Antiretroviral Drugs in HIV-1C-Infected African Patients

W. Wester, M. Wainberg, I. Thior, 2004, Antiviral chemistry & chemotherapy.

UvA-DARE ( Digital Academic Repository ) A prospective , randomized trial of structured treatment interruption for patients with chronic HIV type 1 infection

B. Hirschel, J. Ananworanich, K. Ruxrungtham, 2005 .

Three-Year Durability of Dual-Nucleoside Versus Triple-Nucleoside Therapy in a Thai Population With HIV Infection

K. Ruxrungtham, D. Cooper, P. Phanuphak, 2004, Journal of acquired immune deficiency syndromes.